Citation

Liu YA, Jin Q, Zou Y, Ding Q, Yan S, Wang Z, Hao X, Nguyen B, Zhang X, Pan J, Mo T, Jacobsen K, Lam T, Wu TY, Petrassi HM, Bursulaya B, DiDonato M, Gordon WP, Liu B, Baaten J, Hill R, Nguyen-Tran V, Qiu M, Zhang YQ, Kamireddy A, Espinola S, Deaton L, Ha S, Harb G, Jia Y, Li J, Shen W, Schumacher AM, Colman K, Glynne R, Pan S, McNamara P, Laffitte B, Meeusen S, Molteni V, Loren J.: Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. J Med Chem, Volume 63 (6), 2020

Authors

Ding Q, Hao X, Jin Q, Liu YA, Wang Z, Yan S, Zou Y, Baaten J, Bursulaya B, Colman K, Deaton L, DiDonato M, Espinola S, Glynne R, Gordon WP, Ha S, Harb G, Hill R, Jacobsen K, Jia Y, Kamireddy A, Laffitte B, Lam T, Li J, Liu B, Loren J., McNamara P, Meeusen S, Mo T, Molteni V, Nguyen B, Nguyen-Tran V, Pan J, Pan S, Petrassi HM, Qiu M, Schumacher AM, Shen W, Wu TY, Zhang X, Zhang YQ

Journal

J Med Chem

Year

2020

DOI

10.1021/acs.jmedchem.9b01624

PubMed

32077280

Machine-readable

REST APIRDF